Top Stories

Industry Insights: Pivot to Growth - Jim Margaritis - Vice President, APAC Cluster Head and General Manager Australia and New Zealand Teva Pharmaceuticals.

2024 Year in Review: A Year of Growth and Innovation

Teva’s 2023 Healthy Future Report

Covid 19 virus

Coronavirus (COVID-19) Teva Australia

Teva logo

Update Regarding COVID-19

product shelves

Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility

a young patient receives chemotherapy at the Black Lion Hospital in Addis Ababa, Photo courtesy of the Access to Childhood Cancer Essentials( ACCESS) Initiative

Moving at light speed